Gating Modulation of the Tumor-Related Kv10.1 Channel by Mibefradil

J Cell Physiol. 2017 Aug;232(8):2019-2032. doi: 10.1002/jcp.25448. Epub 2017 Jan 11.

Abstract

Several reports credit mibefradil with tumor suppressing properties arising from its known inhibition of Ca2+ currents. Given that mibefradil (Mb) is also known to inhibit K+ channels, we decided to study the interaction between this organic compound and the tumor-related Kv10.1 channel. Here we report that Mb modulates the gating of Kv10.1. Mb induces an apparent inactivation from both open and early closed states where the channels dwell at hyperpolarized potentials. Additionally, Mb accelerates the kinetics of current activation, in a manner that depends on initial conditions. Our observations suggest that Mb binds to the voltage sensor domain of Kv10.1 channels, thereby modifying the gating of the channels in a way that in some, but not all, aspects opposes to the gating effects exerted by divalent cations. J. Cell. Physiol. 232: 2019-2032, 2017. © 2016 Wiley Periodicals, Inc.

MeSH terms

  • Binding Sites
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors*
  • Ether-A-Go-Go Potassium Channels / genetics
  • Ether-A-Go-Go Potassium Channels / metabolism
  • HEK293 Cells
  • Humans
  • Ion Channel Gating / drug effects*
  • Kinetics
  • Membrane Potentials
  • Mibefradil / metabolism
  • Mibefradil / pharmacology*
  • Models, Biological
  • Potassium Channel Blockers / metabolism
  • Potassium Channel Blockers / pharmacology*
  • Protein Binding
  • Transfection

Substances

  • Ether-A-Go-Go Potassium Channels
  • KCNH1 protein, human
  • Potassium Channel Blockers
  • Mibefradil